12:00 AM
Nov 23, 2009
 |  BC Week In Review  |  Financial News  |  Completed Offerings

ThromboGenics completes private placement

ThromboGenics N.V. (Euronext:THR), Leuven, Belgium
Business: Cardiovascular, Ophthalmic
Date completed: 11/17/09

Read the full 38 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >